NYSE:DHRLife Sciences
Danaher (DHR) Expands Ebola Testing And AI Drug Filing Push Through Two Subsidiaries
Cepheid, a Danaher subsidiary, has rapidly deployed new diagnostic tests in response to an Ebola outbreak, expanding access to frontline public health tools.
IDBS, another Danaher business, has partnered with Alchemi to apply AI to biopharma data management, aiming to speed up regulatory filings.
Together, these updates highlight NYSE:DHR using its portfolio to address urgent health threats and regulatory bottlenecks, beyond typical financial headlines.
Danaher, trading on the NYSE under...